{"transactions":[{"id":2493199,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-30T23:31:50.000Z","date":"2021-11-24","kind":"grant","acquired":true,"shares":112500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."}],"balance_after":112500,"derivative":{"exercise_price":1.39,"expiration_date":"2031-10-18","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0000899243-21-046332","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046332/doc4a.xml","form_type":"4/A","original_submission_date":"2021-11-29"}},{"id":2493198,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-30T23:31:50.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2031-10-18","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-21-046332","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046332/doc4a.xml","form_type":"4/A","original_submission_date":"2021-11-29"}},{"id":2493197,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-30T23:31:50.000Z","date":"2021-11-24","kind":"grant","acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"56,250 shares vested on August 31, 2020; the balance vested in equal amounts on November 30, 2020, February 28, 2021, and May 31, 2021."}],"balance_after":225000,"derivative":{"exercise_price":6.15,"expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-21-046332","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046332/doc4a.xml","form_type":"4/A","original_submission_date":"2021-11-29"}},{"id":2493196,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-30T23:31:50.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"56,250 shares vested on August 31, 2020; the balance vested in equal amounts on November 30, 2020, February 28, 2021, and May 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":6.15,"expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-21-046332","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046332/doc4a.xml","form_type":"4/A","original_submission_date":"2021-11-29"}},{"id":2493195,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-30T23:31:50.000Z","date":"2021-11-24","kind":"grant","acquired":true,"shares":36986,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."}],"balance_after":36986,"derivative":{"exercise_price":1.05,"exercise_date":"2020-06-01","expiration_date":"2030-01-18","underlying":"Common Stock","underlying_shares":36986},"source":{"system":"sec-edgar","filing":"0000899243-21-046332","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046332/doc4a.xml","form_type":"4/A","original_submission_date":"2021-11-29"}},{"id":2493194,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-30T23:31:50.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":36986,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on December 1, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."}],"balance_after":0,"derivative":{"exercise_price":1.05,"exercise_date":"2020-06-01","expiration_date":"2030-01-18","underlying":"Common Stock","underlying_shares":36986},"source":{"system":"sec-edgar","filing":"0000899243-21-046332","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046332/doc4a.xml","form_type":"4/A","original_submission_date":"2021-11-29"}},{"id":2493926,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-29T23:19:53.000Z","date":"2021-11-24","kind":"grant","acquired":true,"shares":93750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on November 30, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on November 30, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."}],"balance_after":93750,"derivative":{"exercise_price":1.39,"expiration_date":"2031-10-18","underlying":"Common Stock","underlying_shares":93750},"source":{"system":"sec-edgar","filing":"0000899243-21-046244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046244/doc4.xml","form_type":"4"}},{"id":2493925,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-29T23:19:53.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on November 30, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on November 30, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."}],"balance_after":0,"derivative":{"exercise_price":1.39,"expiration_date":"2031-10-18","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-21-046244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046244/doc4.xml","form_type":"4"}},{"id":2493924,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-29T23:19:53.000Z","date":"2021-11-24","kind":"grant","acquired":true,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on November 30, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"56,250 shares vested on August 31, 2020; the balance vested in equal amounts on November 30, 2020, February 28, 2021, and May 31, 2021."}],"balance_after":225000,"derivative":{"exercise_price":6.15,"expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-21-046244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046244/doc4.xml","form_type":"4"}},{"id":2493923,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-29T23:19:53.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":225000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on November 30, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"56,250 shares vested on August 31, 2020; the balance vested in equal amounts on November 30, 2020, February 28, 2021, and May 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":6.15,"expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-21-046244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046244/doc4.xml","form_type":"4"}},{"id":2493922,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-29T23:19:53.000Z","date":"2021-11-24","kind":"grant","acquired":true,"shares":36986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on November 30, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."}],"balance_after":36986,"derivative":{"exercise_price":1.05,"exercise_date":"2020-06-01","expiration_date":"2030-01-18","underlying":"Common Stock","underlying_shares":36986},"source":{"system":"sec-edgar","filing":"0000899243-21-046244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046244/doc4.xml","form_type":"4"}},{"id":2493921,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-11-29T23:19:53.000Z","date":"2021-11-24","kind":"disposition_to_issuer","acquired":false,"shares":36986,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The term of the Reporting Person's Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")) as a director of the Issuer ended as of the conclusion of the Issuer's 2021 Annual Meeting of Stockholders on November 24, 2021. Effective immediately prior to the end of the Reporting Person's Continuous Service, each outstanding stock option that had been granted to the Reporting Person under the 2012 Plan was amended to (a) vest and become immediately exercisable, to the extent it would have become vested on November 30, 2021, with the balance of the unvested portion of such option, if any, immediately forfeited, and (b) cause the option to remain exercisable through the original expiration date instead of terminating 90 days following the end of the Reporting Person's Continuous Service."}],"balance_after":0,"derivative":{"exercise_price":1.05,"exercise_date":"2020-06-01","expiration_date":"2030-01-18","underlying":"Common Stock","underlying_shares":36986},"source":{"system":"sec-edgar","filing":"0000899243-21-046244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321046244/doc4.xml","form_type":"4"}},{"id":2538581,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2021-10-20T20:09:48.000Z","date":"2021-10-18","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in 12 equal monthly installments beginning on July 1, 2021, subject to Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date."}],"balance_after":225000,"derivative":{"exercise_price":1.39,"expiration_date":"2031-10-18","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-21-040747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000089924321040747/doc4.xml","form_type":"4"}},{"id":3099481,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option","published_at":"2020-06-27T01:31:50.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"56,250 shares vest on August 31, 2020; the balance vests in equal amounts on November 30, 2020, February 28, 2021 and May 31, 2021, subject to amendment to the equity incentive plan."}],"balance_after":225000,"derivative":{"exercise_price":6.15,"expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001807094-20-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000180709420000010/primary_doc.xml","form_type":"4"}},{"id":3305800,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":133046,"kind":"person","name":"TIMMINS ALAN P","position":1,"cik":"0001234898","reported_name":"TIMMINS ALAN P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-23T02:36:13.000Z","date":"2020-01-18","kind":"grant","acquired":true,"shares":36986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest commencing on March 1, 2020 with respect to 11,986 shares and on June 1, 2020 with respect to 25,000 shares."}],"balance_after":36986,"derivative":{"exercise_price":1.05,"expiration_date":"2030-01-18","underlying":"Common Stock","underlying_shares":36986},"source":{"system":"sec-edgar","filing":"0001234898-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000123489820000004/primary_doc.xml","form_type":"4"}}]}